1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
PhytoHealth Corporation

PhytoHealth Corporation

4108.TW
PhytoHealth CorporationTW flagTaiwan Stock Exchange
12.35
TWD
-0.15
- -
2.45BMarket Cap

Total Valuation

PhytoHealth Corporation carries a market capitalization of 2.45B, placing it among publicly traded companies globally. Its enterprise value stands at 2.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.45B
Enterprise Value2.21B

Share Statistics

PhytoHealth Corporation currently has 198.62M shares outstanding.

Shares Outstanding198.62M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 21.17, and the price-to-book ratio stands at 1.67.

PE RatioN/A
PS Ratio21.17
PB Ratio1.67
P/TBV Ratio1.28
P/FCF Ratio-83.37
P/OCF Ratio-71.73

Enterprise Valuation

EV / Sales16.46
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

PhytoHealth Corporation maintains a current ratio of 27.41, meaning it holds 27.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.69, indicating moderate leverage, while an interest coverage ratio of -464.31 demonstrates limited ability to service its debt obligations.

Current Ratio27.41
Quick Ratio23.22
Debt / Equity0.69
Debt / EBITDA-0.09
Interest Coverage-464.31

Financial Efficiency

Return on Equity (ROE)-3.40
Return on Assets (ROA)-2.43
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.66

Taxes

Income Tax-15,000.00
Effective Tax RateN/A

Stock Price Statistics

PhytoHealth Corporation's stock has declined approximately -8.17844% over the past 52 weeks. The 50-day moving average sits at 12.16, while the 200-day moving average is 13.51.

Beta (5Y)N/A
52-Week Price Change-8.17844%
50-Day Moving Average12.16
200-Day Moving Average13.51
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, PhytoHealth Corporation generated 134.58M in revenue and converted that into -58.20M in net income, yielding earnings per share of -0.52. EBITDA reached -174.58M, while operating income came in at -174.58M.

Revenue134.58M
Gross Profit41.29M
Operating Income-174.58M
Pretax Income-110.11M
Net Income-58.20M
EBITDA-174.58M
EBIT-174.58M
Earnings Per Share (EPS)-0.52

Balance Sheet

PhytoHealth Corporation holds 1.07B in cash and equivalents against 15.73M in total debt, resulting in a net debt position of -86.79M. Total book value stands at 1.70B, with working capital of 1.22B providing operational flexibility.

Cash & Cash Equivalents1.07B
Total Debt15.73M
Net Debt-86.79M
Equity (Book Value)1.70B
Book Value Per Share8.08
Working Capital1.22B

Cash Flow

PhytoHealth Corporation produced -39.71M in operating cash flow over the past twelve months. After subtracting -5.54M in capital expenditures, free cash flow totaled -45.26M - equivalent to -0.21 per share.

Operating Cash Flow-39.71M
Capital Expenditures-5.54M
Free Cash Flow-45.26M
FCF Per Share-0.21

Margins

PhytoHealth Corporation operates with a gross margin of 30.68, reflecting its pricing power and cost economics. The operating margin of -129.73 and net profit margin of -43.25 provide insight into operational efficiency.

Gross Margin30.68
Operating Margin-129.73
Pretax Margin-81.82
Profit Margin-43.25
EBITDA Margin-129.73

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.39
FCF Yield-1.20

Stock Splits

PhytoHealth Corporation's most recent stock split took place on January 5, 2021 with a 1000:1031 split ratio.

Last Split Date1/5/2021
Split Ratio1000:1031

Scores

PhytoHealth Corporation posts an Altman Z-Score of 29.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score29.04